KBio2_004080; Spectrum2_001328; D00551; Laudocaine; Medicaine; Fissucain; 136-47-0; SPBio_001455; KBio3_001444; Spectrum3_000562; 4-14-00-01172 (Beilstein Handbook Reference); BENZOIC ACID, p-(BUTYLAMINO)-, 2-(DIMETHYLAMINO)ETHYL ESTER; 2-(dimethylamino)ethyl 4-(butylamino)benzoate; Metraspray; Uromucaesthin; Tetracaina [INN-Spanish]; Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester; Dikain; Prestwick0_000571; Pontocaine; Meethobalm; Amethocaine; Diaethylaminoaethanol ester der p-butylaminobenzoesaeure [German]; BRN 2216051; p-Butylaminobenzoyl-2-dimethylaminoethanol; InChI=1/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H; DivK1c_000607; Niphanoid; Rexocaine; CAS-136-47-0; Dimethylaminoethyl p-butyl-aminobenzoate; p-(Butylamino)benzoic acid, 2-(dimethylamino)ethyl ester; EINECS 202-316-6; Dicaine; 94-24-6; 2-(Dimethylamino)ethyl p-(butylamino)benzoate; Amethocaine (TN); NINDS_000607; Lopac-T-7508; SPBio_002601; Dicain; Tetrakain [Czech]; Intercain; Tetracainum [INN-Latin]; 2-Dimethylaminoethylester kyseliny p-butylaminobenzoove [Czech]; Tetracaine; Tetracaine [USAN:INN]; Prestwick1_000571; KBio1_000607; Anetain; Contralgin; Spectrum4_000351; Spectrum_001032; Medihaler-Tetracaine; KBio2_006648; BENZOIC ACID,4-BUTYLAMINO,2-DIMETHYLAMINOETHYL ESTER PANTOCAIN BASE; KBio2_001512; KBioGR_000781; Tetracaine (USP); KBioSS_001512; NCGC00016049-01; C07526; NCGC00016049-02; Mucaesthin
show less «
